Recro Pharma Operating Expenses 2011-2026 | REPH

Annual Operating Expenses Recro Pharma

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	22.5 M	79.4 M	61.1 M	48.6 M	27.2 M	11.9 M	1.09 M	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
79.4 M	1.09 M	36 M

Quarterly Operating Expenses Recro Pharma

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4.14 M	-	4.72 M	2.8 M	874 K	-	283 K	449 K	206 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
4.72 M	206 K	1.92 M

Operating Expenses of other stocks in the Drug manufacturers industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Aerie Pharmaceuticals AERI	213 M	-	-	$ 754 M	USA
AcelRx Pharmaceuticals ACRX	40.3 M	-	7.5 %	$ 6.35 M	USA
Catalent CTLT	512 M	-	-	$ 11.5 B	USA
Adamis Pharmaceuticals Corporation ADMP	38.9 M	-	0.86 %	$ 117 M	USA
DURECT Corporation DRRX	44.6 M	-	-	$ 50.1 M	USA
Endo International plc ENDP	763 M	-	-	$ 28.9 M	Irlanda
Agile Therapeutics AGRX	30.5 M	-	10.11 %	$ 58.2 M	USA
Canopy Growth Corporation CGC	197 M	$ 1.1	2.84 %	$ 118 M	Canada
Evoke Pharma EVOK	12.6 M	-	-	$ 36.6 M	USA
Alimera Sciences ALIM	71.8 M	-	-	$ 142 M	USA
Cronos Group CRON	154 M	$ 2.64	1.35 %	$ 1.38 B	Canada
Evolus EOLS	107 M	$ 5.68	37.53 %	$ 366 M	USA
Avadel Pharmaceuticals plc AVDL	196 M	-	-	$ 2.06 B	France
Jupiter Wellness JUPW	39.6 M	-	-	$ 33.6 M	USA
China Pharma Holdings CPHI	2.6 M	$ 0.59	6.08 %	$ 10.3 M	China
Cumberland Pharmaceuticals CPIX	35.2 M	$ 3.81	-16.81 %	$ 53.6 M	USA
Calliditas Therapeutics AB (publ) CALT	213 M	-	-0.1 %	$ 2.03 B	Schweden
HEXO Corp. HEXO	106 M	-	2.45 %	$ 38.1 M	Canada
Harrow Health HROW	174 M	$ 40.02	3.65 %	$ 1.47 B	USA
Neoleukin Therapeutics NLTX	55.6 M	-	-	$ 193 M	Canada
Aurora Cannabis ACB	183 M	$ 3.65	4.89 %	$ 86.3 M	Canada
Athenex ATNX	96.7 M	-	-23.39 %	$ 1.76 M	USA
Emergent BioSolutions EBS	558 M	$ 8.95	0.39 %	$ 458 M	USA
ProPhase Labs PRPH	47.1 M	-	-	$ 5.07 M	USA
Assertio Holdings ASRT	133 M	$ 12.19	2.48 %	$ 866 M	USA
Radius Health RDUS	304 M	-	-	$ 1.42 B	USA
Bausch Health Companies BHC	4.96 B	$ 5.67	-0.87 %	$ 2.07 B	Canada
Lannett Company LCI	209 M	-	1.15 %	$ 7.11 M	USA
Eagle Pharmaceuticals EGRX	113 M	-	-39.89 %	$ 27.7 M	USA
Organogenesis Holdings ORGO	368 M	$ 2.87	0.01 %	$ 378 M	USA
OrganiGram Holdings OGI	41.4 M	$ 1.4	2.19 %	$ 402 M	Canada
Rockwell Medical RMTI	31.1 M	$ 0.91	1.03 %	$ 21.2 M	USA
Perrigo Company plc PRGO	2.62 B	$ 11.71	2.81 %	$ 1.62 B	USA
Sundial Growers SNDL	102 K	$ 1.55	1.21 %	$ 3.37 M	Canada
TherapeuticsMD TXMD	9.82 M	$ 2.25	1.35 %	$ 23.5 M	USA
Veru VERU	44 M	$ 2.53	0.4 %	$ 341 M	USA
Viatris VTRS	5.67 B	$ 14.74	-1.04 %	$ 17.7 B	USA
Pacira BioSciences PCRX	279 M	$ 22.92	3.69 %	$ 1.06 B	USA
PetIQ PETQ	138 M	-	1.64 %	$ 400 M	USA
OptiNose OPTN	129 M	-	-	$ 1.08 B	USA
PLx Pharma PLXP	44.2 M	-	-27.8 %	$ 2.56 M	USA
Relmada Therapeutics RLMD	104 M	$ 4.79	2.57 %	$ 144 M	USA
cbdMD YCBD	28.9 M	$ 0.75	-2.76 %	$ 3.23 M	USA
SCYNEXIS SCYX	67.5 M	$ 0.76	1.22 %	$ 36.4 M	USA
Solid Biosciences SLDB	130 M	$ 6.14	3.02 %	$ 251 M	USA
Sonoma Pharmaceuticals SNOA	9.18 M	$ 2.74	-0.36 %	$ 3.4 M	USA
Tricida TCDA	153 M	-	-	$ 3.25 M	USA
Tilray TLRY	1.52 B	$ 7.33	-0.48 %	$ 4.53 B	Canada
Zynerba Pharmaceuticals ZYNE	35.3 M	-	-	$ 55.5 M	USA